Effects of terfenadine and diphenhydramine on the CYP2D6 activity in healthy volunteers
Autor: | Atila Bozkurt, S. Oguz Kayaalp, Nursabah E. Basci, Selim Kortunay |
---|---|
Rok vydání: | 2002 |
Předmět: |
Adult
Male CYP2D6 Pharmacology High-performance liquid chromatography Statistics Nonparametric chemistry.chemical_compound In vivo Healthy volunteers Medicine Humans Pharmacology (medical) Terfenadine business.industry Diphenhydramine Debrisoquin Debrisoquine chemistry Cytochrome P-450 CYP2D6 Histamine H1 Antagonists Antihistaminic drugs business medicine.drug |
Zdroj: | European journal of drug metabolism and pharmacokinetics. 27(3) |
ISSN: | 0378-7966 |
Popis: | The aim of this study was to investigate the effects of two antihistaminic drugs, terfenadine and diphenhydramine on CYP2D6 activity by using debrisoquine as a model substrate. The study was carried out as an in vivo single-dose study in 12 young, healthy men. All volunteers had previously been identified as debrisoquine-extensive metabolisers. The volunteers took increasing single oral doses of one of the two antihistaminic drugs in randomized order, at weeklyy intervals, followed 1 h later by debrisoquine test. Terfenadine and diphhenhydramine were given in the doses of 60 and 120 mg; 100 and 150 mg, respectively. The 8-hr urinary concentrations of debrisoquine and 4-hydroxydebrisoquine were determined by high-performance liquid chromatography (HPLC). With increasing doses of terfenadine and diphenhydramine, there was no statistically significant increase in the debrisoquine metabolic ratios (P>0.05, Page’s test for trend). The difference between the median debrisoquine metabolic ratios before and after treatments with terfenadine or diphenhydramine were not statistically significant (Wilcoxon’s test). This investigation indicates that single-dose administration of diphenhydramine or terfenadine has no effect on the CYP2D6-mediated hydroxylation of debrisoquine in healthy volunteers. |
Databáze: | OpenAIRE |
Externí odkaz: |